Literature DB >> 10085095

Leukotriene binding, signaling, and analysis of HIV coreceptor function in mouse and human leukotriene B4 receptor-transfected cells.

V Martin1, P Ronde, D Unett, A Wong, T L Hoffman, A L Edinger, R W Doms, C D Funk.   

Abstract

The mouse leukotriene B4 receptor (m-BLTR) gene was cloned. Membrane fractions of human embryonic kidney 293 cells stably expressing m-BLTR demonstrated a high affinity and specific binding for leukotriene B4 (LTB4, Kd = 0.24 +/- 0.03 nM). In competition binding experiments, LTB4 was the most potent competitor (Ki = 0.23 +/- 0.05 nM) followed by 20-hydroxy-LTB4 (Ki = 1.1 +/- 0.2 nM) and by 6-trans-12-epi-LTB4 and LTD4 (Ki > 1 microM). In stably transfected Chinese hamster ovary cells, LTB4 inhibited forskolin-activated cAMP production and induced an increase of intracellular calcium, suggesting that this receptor is coupled to Gi- and Go-like proteins. In Xenopus laevis melanophores transiently expressing m-BLTR, LTB4 induced the aggregation of pigment granules, confirming the inhibition of cAMP production induced by LTB4. BLT receptors share significant sequence homology with chemokine receptors (CCR5 and CXCR4) that act as human immunodeficiency virus (HIV) coreceptors. However, among the 16 HIV/SIV strains tested, the human BLT receptor did not act as a coreceptor for virus entry into CD4-expressing cells based on infection and cell-cell fusion assays. In 5-lipoxygenase-deficient mice, the absence of leukotriene B4 biosynthesis did not detectably alter m-BLT receptor binding in membranes obtained from glycogen-elicited neutrophils. Isolation of the m-BLTR gene will form the basis of future experiments to elucidate the selective role of LTB4, as opposed to cysteinyl-leukotrienes, in murine models of inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085095     DOI: 10.1074/jbc.274.13.8597

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Patterns of Human Immunodeficiency Virus type 1 recombination ex vivo provide evidence for coadaptation of distant sites, resulting in purifying selection for intersubtype recombinants during replication.

Authors:  Andrea Galli; Mary Kearney; Olga A Nikolaitchik; Sloane Yu; Mario P S Chin; Frank Maldarelli; John M Coffin; Vinay K Pathak; Wei-Shau Hu
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.

Authors:  N Chiang; K Gronert; C B Clish; J A O'Brien; M W Freeman; C N Serhan
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

3.  Anethole and eugenol reduce in vitro and in vivo leukocyte migration induced by fMLP, LTB4, and carrageenan.

Authors:  Camila Fernanda Estevão-Silva; Raquel Kummer; Fernanda Carolina Fachini-Queiroz; Renata Grespan; Gessilda Alcântara Nogueira de Melo; Silmara Baroni; Roberto Kenji Nakamura Cuman; Ciomar Aparecida Bersani-Amado
Journal:  J Nat Med       Date:  2014-05-01       Impact factor: 2.343

4.  Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.

Authors:  Y Zhang; B Lou; R B Lal; A Gettie; P A Marx; J P Moore
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils.

Authors:  Mireille St-Onge; Nicolas Flamand; Jordane Biarc; Serge Picard; Line Bouchard; Andrée-Anne Dussault; Cynthia Laflamme; Michael J James; Gillian E Caughey; Leslie G Cleland; Pierre Borgeat; Marc Pouliot
Journal:  Biochim Biophys Acta       Date:  2007-06-28

6.  Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells.

Authors:  Jonathan Bertin; Corinne Barat; Dave Bélanger; Michel J Tremblay
Journal:  J Neuroinflammation       Date:  2012-03-16       Impact factor: 8.322

7.  Cell-specific transcriptional regulation of human leukotriene B(4) receptor gene.

Authors:  K Kato; T Yokomizo; T Izumi; T Shimizu
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

8.  A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.

Authors:  T Yokomizo; K Kato; K Terawaki; T Izumi; T Shimizu
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

9.  Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis.

Authors:  B Haribabu; M W Verghese; D A Steeber; D D Sellars; C B Bock; R Snyderman
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

10.  Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals.

Authors:  Cynthia de la Fuente; Francisco Santiago; Longwen Deng; Carolyne Eadie; Irene Zilberman; Kylene Kehn; Anil Maddukuri; Shanese Baylor; Kaili Wu; Chee Gun Lee; Anne Pumfery; Fatah Kashanchi
Journal:  BMC Biochem       Date:  2002-06-10       Impact factor: 4.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.